Richard Traynor
General Counsel chez CERTARA, INC.
Fortune : 3 M $ au 31/03/2024
Profil
Richard Michael Traynor is currently the Secretary & Director at LA-SER Europe Ltd., the Director at Certara UK Holdings Ltd., the Secretary at Certara USA, Inc., the Senior Vice President & General Counsel at Certara Holdco, Inc., and the Secretary, Senior Vice President & General Counsel at Certara, Inc. Previously, he worked as the Chief Legal & Compliance Officer at LifeCell Corp.
from 2012 to 2017 and as the Associate General Counsel at Edge Therapeutics, Inc. from 2017 to 2018.
He also served as a Partner at Porzio, Bromberg & Newman PC.
Traynor completed his undergraduate degree at the University of Notre Dame in 1994 and obtained his graduate degree from the University of Virginia School of Law in 1998.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CERTARA, INC.
0,11% | 01/04/2024 | 173 524 ( 0,11% ) | 3 M $ | 31/03/2024 |
Postes actifs de Richard Traynor
| Sociétés | Poste | Début |
|---|---|---|
| CERTARA, INC. | General Counsel | 01/03/2018 |
Certara UK Holdings Ltd.
 Certara UK Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Certara, Inc., Certara UK Holdings Ltd. is a private company that develops drug therapies. The company is based in London, UK. Certara UK Holdings was founded in 2004. | Director/Board Member | 20/06/2018 |
LA-SER Europe Ltd.
 LA-SER Europe Ltd. Pharmaceuticals: MajorHealth Technology LA-SER is a strongly science driven late-phase company with offices in 7 countries (UK, France, Germany, Spain, Italy, Canada and Morocco) encompassing a team of 150 specialists in late-phase clinical research. They cover a full range of late-phase services from observational studies, cohorts, registries, case-control studies, surveys, electronic health care database studies, pragmatic trials, they excel in risk/benefit management, effectiveness/relative effectiveness studies, and strategic consulting for drug value assessment. A truly unique feature is their in-depth understanding & knowledge of the process of drug value assessment, and of the methods, paradigms & modus operandi of regulatory decision-making bodies & agencies in several countries. Originally brought to the company by the founders of the company, this in-depth network knowledge is now shared by a large number of their senior staff. They can therefore provide remarkable insight into what evidence is required to grant market authorisation & reimbursement, for new drugs across different European countries & North America. | Director/Board Member | 16/04/2018 |
Certara USA, Inc.
 Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | Corporate Secretary | - |
Certara Holdco, Inc.
 Certara Holdco, Inc. Miscellaneous Commercial ServicesCommercial Services Certara Holdco, Inc. operates as holding company whose subsidiary provides decision support technology and consulting services for optimizing drug development and improving health outcomes. The company is headquartered in DE. | General Counsel | 01/03/2018 |
Anciens postes connus de Richard Traynor
| Sociétés | Poste | Fin |
|---|---|---|
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Corporate Officer/Principal | 01/03/2018 |
LifeCell Corp.
 LifeCell Corp. BiotechnologyHealth Technology LifeCell Corp. develops and markets tissue repair products. The firm focuses on reconstructive, urogynecologic and orthopedic surgical procedures. Its products include alloderm, strattice, graft jacket, allocraftdbm and repliform. The company was founded in 1986 and is headquartered in Branchburg, NJ. | Compliance Officer | 01/01/2017 |
Porzio, Bromberg & Newman PC
 Porzio, Bromberg & Newman PC Miscellaneous Commercial ServicesCommercial Services Porzio, Bromberg & Newman PC provides legal services. Its practice area include bankruptcy, data privacy and cyber security, FDA, litigation, real estate and intellectual property. The company was founded in 1962 and is headquartered in Morristown, NJ. | Corporate Officer/Principal | - |
Formation de Richard Traynor
| University of Notre Dame | Undergraduate Degree |
| University of Virginia School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CERTARA, INC. | Technology Services |
| Entreprise privées | 7 |
|---|---|
LifeCell Corp.
LifeCell Corp. BiotechnologyHealth Technology LifeCell Corp. develops and markets tissue repair products. The firm focuses on reconstructive, urogynecologic and orthopedic surgical procedures. Its products include alloderm, strattice, graft jacket, allocraftdbm and repliform. The company was founded in 1986 and is headquartered in Branchburg, NJ. | Health Technology |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Health Technology |
Porzio, Bromberg & Newman PC
Porzio, Bromberg & Newman PC Miscellaneous Commercial ServicesCommercial Services Porzio, Bromberg & Newman PC provides legal services. Its practice area include bankruptcy, data privacy and cyber security, FDA, litigation, real estate and intellectual property. The company was founded in 1962 and is headquartered in Morristown, NJ. | Commercial Services |
Certara USA, Inc.
Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | Commercial Services |
LA-SER Europe Ltd.
LA-SER Europe Ltd. Pharmaceuticals: MajorHealth Technology LA-SER is a strongly science driven late-phase company with offices in 7 countries (UK, France, Germany, Spain, Italy, Canada and Morocco) encompassing a team of 150 specialists in late-phase clinical research. They cover a full range of late-phase services from observational studies, cohorts, registries, case-control studies, surveys, electronic health care database studies, pragmatic trials, they excel in risk/benefit management, effectiveness/relative effectiveness studies, and strategic consulting for drug value assessment. A truly unique feature is their in-depth understanding & knowledge of the process of drug value assessment, and of the methods, paradigms & modus operandi of regulatory decision-making bodies & agencies in several countries. Originally brought to the company by the founders of the company, this in-depth network knowledge is now shared by a large number of their senior staff. They can therefore provide remarkable insight into what evidence is required to grant market authorisation & reimbursement, for new drugs across different European countries & North America. | Health Technology |
Certara Holdco, Inc.
Certara Holdco, Inc. Miscellaneous Commercial ServicesCommercial Services Certara Holdco, Inc. operates as holding company whose subsidiary provides decision support technology and consulting services for optimizing drug development and improving health outcomes. The company is headquartered in DE. | Commercial Services |
Certara UK Holdings Ltd.
Certara UK Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Certara, Inc., Certara UK Holdings Ltd. is a private company that develops drug therapies. The company is based in London, UK. Certara UK Holdings was founded in 2004. | Commercial Services |
